Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Hinnen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Science of Diabetes Self-Management and Care|August 1, 2023
Certification: A Transformational Trajectory in PracticeDeborah Hinnen
Diabetes Spectrum : a Publication of the American Diabetes Association|August 30, 2017
Glucagon-Like Peptide 1 Receptor Agonists for Type 2 DiabetesDeborah Hinnen
Therapeutic Advances in Endocrinology and Metabolism|May 6, 2015
Short commentary on empagliflozin and its potential clinical impactDeborah Hinnen
Therapeutic Advances in Endocrinology and Metabolism|July 3, 2015
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetesDeborah Hinnen
The Diabetes Educator|October 11, 2015
Dipeptidyl Peptidase-4 Inhibitors in Diverse Patient Populations With Type 2 DiabetesDeborah Hinnen
Clinical Diabetes : a Publication of the American Diabetes Association|February 6, 2015
Clinical implications of canagliflozin treatment in patients with type 2 diabetesVirginia Valentine, Deborah Hinnen
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 2, 2019
Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trialsDeborah Hinnen, Davida F Kruger
The Diabetes Educator|July 29, 2006
Cardiovascular event prevention in the person with type 2 diabetes: case examples for identifying and treating multiple risksAshok Balasubramanyam, Deborah Hinnen, William Polonsky
Journal of the American Board of Family Medicine : JABFM|November 9, 2006
Incretin mimetics and DPP-IV inhibitors: new paradigms for the treatment of type 2 diabetesDeborah Hinnen, Loretta L Nielsen, Amy Waninger, et al.
The Journal of Family Practice|May 6, 2011
It's time to abandon the sliding scaleDiana W Guthrie, Richard A Guthrie, Deborah Hinnen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Science of Diabetes Self-Management and Care|August 1, 2023
Certification: A Transformational Trajectory in PracticeDeborah Hinnen
Diabetes Spectrum : a Publication of the American Diabetes Association|August 30, 2017
Glucagon-Like Peptide 1 Receptor Agonists for Type 2 DiabetesDeborah Hinnen
Therapeutic Advances in Endocrinology and Metabolism|May 6, 2015
Short commentary on empagliflozin and its potential clinical impactDeborah Hinnen
Therapeutic Advances in Endocrinology and Metabolism|July 3, 2015
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetesDeborah Hinnen
The Diabetes Educator|October 11, 2015
Dipeptidyl Peptidase-4 Inhibitors in Diverse Patient Populations With Type 2 DiabetesDeborah Hinnen
Clinical Diabetes : a Publication of the American Diabetes Association|February 6, 2015
Clinical implications of canagliflozin treatment in patients with type 2 diabetesVirginia Valentine, Deborah Hinnen
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 2, 2019
Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trialsDeborah Hinnen, Davida F Kruger
The Diabetes Educator|July 29, 2006
Cardiovascular event prevention in the person with type 2 diabetes: case examples for identifying and treating multiple risksAshok Balasubramanyam, Deborah Hinnen, William Polonsky
Journal of the American Board of Family Medicine : JABFM|November 9, 2006
Incretin mimetics and DPP-IV inhibitors: new paradigms for the treatment of type 2 diabetesDeborah Hinnen, Loretta L Nielsen, Amy Waninger, et al.
The Journal of Family Practice|May 6, 2011
It's time to abandon the sliding scaleDiana W Guthrie, Richard A Guthrie, Deborah Hinnen, et al.
Pageof 2